Koichi Miyamura
Overview
Explore the profile of Koichi Miyamura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
166
Citations
1638
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Teshima T, Onishi Y, Kato K, Taniguchi S, Miyamura K, Fukushima K, et al.
Int J Hematol
. 2024 May;
120(1):106-116.
PMID: 38796666
Acute graft-versus-host disease (aGvHD) is a major complication after allogeneic hematopoietic stem cell transplantation in Japan and other countries. Nearly one-third of patients do not respond to standard systemic steroid...
2.
Ohbiki M, Ito Y, Inamoto Y, Miyamura K, Uchida N, Fukuda T, et al.
Transplant Cell Ther
. 2023 Sep;
29(12):768.e1-768.e10.
PMID: 37739224
Allogeneic (allo-) hematopoietic cell transplantation (HCT) has evolved as a curative therapy for hematologic malignancies and diseases, with practice changes over the past 2 decades. This study aimed to evaluate...
3.
Sato T, Kawashima N, Ito M, Atsuta Y, Kagaya Y, Seto A, et al.
Blood Cell Ther
. 2023 Jan;
3(4):84-91.
PMID: 36711006
Residual disease (RD) is one of the risk factors for relapse after hematopoietic stem cell transplantation (HSCT) in hematological malignancies. Although recent advances in the technology for detecting minimal/measurable RD,...
4.
Matsuda A, Imada K, Obara N, Iida H, Yamazaki H, Tomiyama Y, et al.
Am J Clin Pathol
. 2022 Aug;
158(5):604-615.
PMID: 36018052
Objectives: Eltrombopag, a thrombopoietin-receptor agonist, stimulates hematopoiesis in patients with acquired aplastic anemia (AA). Cytomorphologic changes in bone marrow after eltrombopag administration are still unclear. This study examined the effect...
5.
Kanda Y, Doki N, Kojima M, Kako S, Inoue M, Uchida N, et al.
Transplant Cell Ther
. 2022 Jul;
28(10):677.e1-677.e6.
PMID: 35803526
During the COVID-19 pandemic, donor grafts are frequently cryopreserved to ensure that a graft is available before starting a conditioning regimen. However, there have been conflicting reports on the effect...
6.
Ando T, Kamoshita S, Riku Y, Ito A, Ozawa Y, Miyamura K, et al.
Neuropathology
. 2022 May;
42(4):295-301.
PMID: 35607714
Neurolymphomatosis is a neurological manifestation of lymphoma that involves the cranial or spinal peripheral nerves, nerve roots, and plexus with direct invasion of neoplastic cells. Neurolymphomatosis is rare among patients...
7.
Hattori T, Goto T, Osaki M, Ozawa Y, Miyamura K
Infection
. 2022 Jan;
50(3):753-759.
PMID: 35013943
Purpose: Due to the increasing prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales, empirical therapies with cefepime or piperacillin/tazobactam for hematology patients with febrile neutropenia have become ineffective. Carbapenems should be administered...
8.
Kako S, Hayakawa F, Miyamura K, Tanaka J, Imai K, Kanda J, et al.
Transplant Cell Ther
. 2021 Dec;
28(3):161.e1-161.e10.
PMID: 34875401
An HLA-matched relative is the first-choice donor for patients with Philadelphia chromosome (Ph)-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR1). The most promising alternative donor is thought to...
9.
Tsuzuki S, Yasuda T, Kojima S, Kawazu M, Akahane K, Inukai T, et al.
Blood Cancer Discov
. 2021 Oct;
1(1):82-95.
PMID: 34661142
Significance: Cancer type-specific gene expression is governed by transcription factors involved in a highly interconnected autoregulatory loop called CRC. Here, we characterized fusion protein-driven CRC and identified its pharmacologic vulnerabilities,...
10.
Sato T, Goto M, Ohbiki M, Goto T, Morishita T, Seto A, et al.
Int J Hematol
. 2021 Aug;
114(6):682-690.
PMID: 34420193
Infection is one of the major causes of death in hematopoietic stem cell transplantation (HSCT) survivors. Precise assessments of immune function after HSCT will be critical in establishing appropriate treatment...